ArticleFrontiers in aging2026
Coronary angiography-derived microcirculatory resistance predicts adverse cardiovascular events in elderly with unstable angina post-percutaneous coronary intervention.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary microvascular dysfunction (CMD) has been increasingly recognized as a critical determinant of adverse cardiovascular outcomes. The coronary angiography-derived index of microcirculatory resistance (caIMR) has emerged as a promising noninvasive tool for CMD assessment, yet its prognostic value in elderly patients with unstable angina (UA) following percutaneous coronary intervention (PCI) remains insufficiently explored. Methods: This single-center retrospective cohort study enrolled 348 elderly UA patients (age ≥65 years) who underwent PCI between June 2022 and February 2024. Patients were stratified by post-PCI caIMR using a cutoff value of 2.50 mmHg s/cm. The primary endpoint was major adverse cardiovascular events (MACE), including myocardial infarction, stroke, heart failure, angina rehospitalization, and cardiovascular death. Multivariable Cox regression and subgroup analyses were performed to evaluate the prognostic consistency of caIMR across different patient characteristics. Results: Patients with caIMR ≥2.50 mmHg s/cm demonstrated significantly higher MACE rates. Multivariable analysis confirmed caIMR as an independent predictor, with diabetes mellitus also showing predictive value. Subgroup analyses revealed consistent prognostic value of caIMR regardless of hypertension status or diabetes. Conclusion: Noninvasive caIMR assessment effectively stratifies post-PCI risk in elderly UA patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.